Evidence map›Paper›PMID 37109194›Full record

ArticleJournal of clinical medicine2023

Characteristics of Asthma Exacerbations in Emergency Care in Switzerland-Demographics, Treatment, and Burden of Disease in Patients with Asthma Exacerbations Presenting to an Emergency Department in Switzerland (CARE-S).

Marco Rueegg, Jeannette-Marie Busch, Peter van Iperen, Joerg D Leuppi, Roland Bingisser

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Marco RueeggEmergency Department, University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0001-5771-8900
Jeannette-Marie BuschUniversity Center of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland.
Peter van IperenDepartment of Respiratory and Immunology Biologics, AstraZeneca AG, 6340 Baar, Switzerland.
Joerg D LeuppiUniversity Center of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland.ORCID 0000-0002-5554-0675
Roland BingisserEmergency Department, University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0001-8223-9792
University of Basel · CHAstraZeneca (Switzerland) · CHUniversity Hospital of Basel · CH

Funding

AstraZeneca (Switzerland) N/A
6 · The paper itself

Abstract

Emergency care for asthma is provided by general practitioners, pulmonologists, and emergency departments (EDs). Although it is known that patients presenting to EDs with acute asthma exacerbations are a vulnerable population and that this mode of presentation is a risk marker for more severe complications, research on this population is scarce. We conducted a retrospective study on patients with asthma exacerbations who presented to the ED of the University Hospital Basel, Switzerland, during 2017-2020. Of the last 200 presentations, 100 were selected and analyzed to assess demographic information, the use of previous and ED-prescribed asthma medication, and clinical outcomes after a mean period of time of 18 months. Of these 100 asthma patients, 96 were self-presenters, and 43 had the second highest degree of acuity (emergency severity index 2). Global Initiative for Asthma (GINA) step 1 and step 3 were the most common among patients with known GINA levels, accounting for 22 and 18 patients, respectively. A total of 4 patients were undergoing treatment with oral corticosteroids at presentation, and 34 were at discharge. At presentation, 38 patients used the combination therapy of inhaled corticosteroid/long-acting β

Indexed as

asthma exacerbationasthma treatment patternemergency careGINA 2021medical shortcomings

Identifiers

PMID37109194
PMCPMC10146778
OpenAlexW4365509125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.